VanEck Associates’s Caris Life Sciences CAI Stock Holding History
Bought
Maintained
Sold
Other funds holding CAI
VanEck Associates's CAI Position: Q3 2026 in Review
VanEck Associates opened a new position in Caris Life Sciences (CAI) in Q3 2026: 10,012 shares worth $307K. The stake represents ﹤0.01% of the portfolio and ranks #1281 among its holdings.
328 funds tracked by Wall St. Rank hold CAI as of Q3 2026.
- VanEck Associates held 10,012 shares of Caris Life Sciences worth $307K as of Q3 2026.
- Caris Life Sciences was a new VanEck Associates position in Q3 2026.
- Caris Life Sciences made up ﹤0.01% of VanEck Associates's portfolio in Q3 2026, its #1281 holding.
- 328 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2026.
Based on VanEck Associates's 13F filing for Q3 2026, filed 13 Nov 2026.